°¢¶û´Äº£Ä¬²¡£¨Alzheimer's disease£¬AD£©£¬Ë׳ÆÔçÀÏÐÔ³Õ´ô¡¢ÍíÄê³Õ´ô¡¢³Õ´ôÖ¢£¬ÊÇÒ»ÖÖ·¢²¡Àú³Ì»ºÂý¡¢Ëæ×Åʱ¼äÒ»Ö±¶ñ»¯µÄÉñ¾ÍË»¯ÐÔ¼²²¡¡£ÆäΪÁÙ´²×î³£¼ûÉñ¾ÈÏÖªÕϰ£¬ÑÏÖØÓ°Ï컼ÕßÉúÑÄÖÊÁ¿¼°Ô¤ÆÚÊÙÃü¡£°¢¶û´Äº£Ä¬²¡ÍùÍùÆð²¡½ÏΪÒþÄ䣬²¢¾ßÓн¥½ø²»¿ÉÄæÐÔ£¬ÍíÄêȺÌåÆÕ±é»¼²¡ÂʸßÇÒÎÞ·¨ÖÎÓú¡£¸Ã²¡²¡Ö¢Ö÷ÒªÌåÏÖΪӰÏóËðʧºÍ¾ÙÐÐÐÔÉñ¾ÈÏÖª¹¦Ð§Õϰ£¬Ê¹µÃÖÇÄÜϽµ¡¢ÐÔ¸ñÐÐΪģʽ¸Ä±ä£¬½ø¶ø×ÔÀíÄÜÁ¦¼õÍË£¬Ò»Ñùƽ³£ÉúÑÄÑÏÖØÊܵ½ÑÏÖØÓ°Ïì£¬ÖØ¶È°¢¶û´Äº£Ä¬²¡»¼Õß³£ºÏ²¢ÓªÑø²»Á¼¡¢·Î²¿¼°ÃÚÄòϵͳѬȾ¡¢Ñ¹´¯µÈ²¢·¢Ö¢£¬ÉõÖÁÈ«ÉíÐÔË¥½ß£¬ÏÔÖøÓ°Ï컼ÕßÔ¤ÆÚÊÙÃü¡£
±í1£º³Õ´ôÖ¢·ÖÐͼ°Õ¼±È[1]
ÎÒ¹ú°¢¶û´Äº£Ä¬²¡»¼ÕßÊýÄ¿ÖØ´ó£¬ºã¾ÃÕչ˻¤Ê¿¼°ºÏ²¢Ö¢ÖÎÁÆÒýÆð½ÏÖØÉç»á¼ç¸º¡£2022ÄêÎÒ¹ú60ËêÒÔÉÏÉú³Ý³¬2.8ÒÚ£¬¸ÃȺÌåÈÏÖªÕϰ»¼²¡ÂÊԼΪ6.04%£¬ÆäÖа¢¶û´Äº£Ä¬²¡Õ¼±ÈÔ¼60%-80%£¬¶ÔÓ¦»¼ÕßÈËÊý1000-1400ÍòÈË£¬²¢Ëæ×ÅÉú³ÝÀÏÁ仯¼ÓÉî³ÊÖðÄêÔöÌíÌ¬ÊÆ£¬Ô¤¼ÆÖÁ2050Äê60ËêÒÔÉÏ»¼²¡ÈËȺ½«³¬3000ÍòÈË£¬µÖ´ïÏÖÓйæÄ£µÄÁ½±¶¡£
°¢¶û´Äº£Ä¬²¡µÄµä·¶²¡Àí¸Ä±äΪ£ºÆÕ±éµÄÉñ¾ÔªÉ¥Ê§µ¼ÖÂÄÔ×é֯ήËõ£¬tauÂѰ×Ì«¹ýÁ×Ëữµ¼ÖµÄÐÂÆ¤²ãºÍº£ÂíÌåÉñ¾ÔªÉñ¾ÏËά²ø½á£¨NFT£©£¬ÄÔÄÚÓдó×ÚµÄβ-µí·ÛÑùÂѰף¨A⣩µÄ³Á»ýÐγÉÍíÄê°ß£¨SP£©¡£ÓÉÓÚÉñ¾ÔªµÄ±äÐΡ¢µòÍöÖ±ÖÁéæÃüÊÇÒ»¸ö¼«ÆäÖØ´óµÄÀú³Ì£¬°üÀ¨¶àÖÖÒòËØÏ໥ӰÏ죬°¢¶û´Äº£Ä¬²¡Ïêϸ·¢²¡»úÖÆÉÐÎÞ¶¨ÂÛ£¬ÏÖÔÚѧ½ç±£´æµÄ»úÖÆÑ§Ëµ°üÀ¨AβÒì³£³Á»ý¡¢TauÂѰ×Ì«¹ýÁ×Ëữ¡¢µ¨¼îÄÜËðÉË¡¢Ñõ»¯Ó¦¼¤¡¢Ñ×ÐÔ·´Ó¦¡¢ÒȵºËØÐźŴ«µ¼Í¨Â·Õϰ¡¢»ùÒòÒì³£ºÍÇéÐÎÒòËØµÈ£¬ÆäÖÐAβÒì³£³Á»ý¼°TauÂѰ×Ì«¹ýÁ×ËữÈϿɶȽϸߡ£
°¢¶û´Äº£Ä¬²¡²¡³Ì½Ï³¤£¨ÊýÄêÖÁÊýÊ®Ä꣩£¬²¡ÀíÐÄÀíÀú³ÌÖ÷Òª¿É·ÖΪÈý¸ö½×¶Î¡£°¢¶û´Äº£Ä¬²¡µÄ±¬·¢ÍùÍùÊÇÒ»¸öÒ»Á¬Àú³Ì£¬Ö÷ÒªÌåÏÖΪÈÏÖª¹¦Ð§Ï½µ¡¢¾«ÉñÖ¢×´ºÍÐÐΪÕϰ¡¢Ò»Ñùƽ³£ÉúÑÄÄÜÁ¦µÄÖð½¥Ï½µ£¬Àú¾Çá¶ÈÈÏÖªÕϰǰÆÚ£¨preMCI£©/ǰÁÙ´²ÆÚ£¨preclinical-AD£©¡¢Çá¶ÈÈÏÖªÕϰÆÚ£¨MCI£©¡¢³Õ´ôÆÚ£¨AD£©£¬¶ÔÓ¦Ò»Á¬Ê±´úÒ»Ñùƽ³£Îª1-3Äê¡¢2-10Äê¡¢8-12Äê¡£
±í2£º°¢¶û´Äº£Ä¬²¡²¡³Ì
³Õ´ôÆÚ»¼ÕßÉíÌåÐÔÄÜÒÑÖð²½ÍË»¯£¬ÈÏÖª¹¦Ð§ÊÜËðÑÏÖØ£¬²¡ÀíÐÄÀí¶à²»¿ÉÄæ£¬¶Ô´Ë½×¶ÎµÄÈÎºÎÆð¾¢ÖÎÁƶ¼ÒÑÊÕЧÉõ΢£¬¹Ê½ñÄ꺣ÄÚΪѧ½çÖð½¥ÊìϤµ½»ù´¡¼°ÁÙ´²Ñо¿´°¿ÚÇ°ÒÆµÄÖ÷ÒªÐÔºÍÐëÒªÐÔ¡£°¢¶û´Äº£Ä¬²¡·¢²¡²¡³Ì²î±ð½×¶ÎµÄÁÙ´²¸ÉԤЧ¹û²î±ð£¬ÔçÆÚɸ²é²¢¸ÉÔ¤ÊÇÔ¤·À¡¢ÑÓ»ºÉõÖÁŤת²¡³ÌÏòADÆÚת»¯µÄÒªº¦£¬¿ÉÏÔÖøÌá¸ß»¼ÕßÉúÑÄÖÊÁ¿¡£¹ØÓÚ´¦ÓÚÔçÆÚ½×¶ÎµÄÇá¶È»¼Õߣ¬¿É¾ÙÐÐÒ©ÎïÖÎÁƺÍÈÏ֪ѵÁ·×ÊÖúÑÓ»º²¡ÇéÏ£Íû£¬ÓÐÍû¼õ»ºÈÏÖª¹¦Ð§Ï½µËÙÂÊ£»¹ØÓÚÖÐÆÚ½×¶ÎµÄÖжȻ¼Õߣ¬ÁÙ´²¸ÉÔ¤Ö÷ÒªÊÇͨ¹ýÒ©ÎïÖÎÁÆ¡¢ÐÐΪ¹ÜÀí¡¢ÐÄÀíÖ§³Ö¡¢Ò»Ñùƽ³£ÉúÑÄÊÖÒÕѵÁ·µÈÊÖ¶ÎÀ´¼õÇᲡ֢²¢Ìá¸ßÉúÑÄÖÊÁ¿¡£¹ØÓÚ´¦ÓÚÍíÆÚµÄÖØ¶È»¼Õߣ¬ÁÙ´²¸ÉÔ¤µÄ×÷ÓýöÌåÏÖÔÚͨ¹ýÕÕ»¤ºÍÖ§³ÖÀ´×ÊÖú»¼Õß¼á³ÖÉíÌåÌñ¾²£¬ïÔ̲¢·¢Ö¢¡£
MCIÆÚÓëAD²¡ÀíÌØÕ÷ÏàËÆ£¬ÎªÁÙ´²·¢Ã÷¼°¸ÉÔ¤Òªº¦Ê±ÆÚ¡£MCIÆÚΪÕý³£ÀÏÁ仯ºÍ³Õ´ôÖ®¼äµÄ¹ý¶É״̬£¬²¢ÓÐÏòADÉú³¤µÄÇ÷ÊÆ£¬´¦ÓÚ¸ÃʱÆÚ»¼Õß×ÝÈ»βÑùµí·ÛÂѰ×ÃܶÈÕý³££¬Éñ¾ÔªÏËά²ø½áÃܶÈͨ³£´óÓÚÕý³£ÐàÂõÈËȺ£¬ÇÒϸ°ûÍâµÍ¾ÛtauÂѰ׿ÉÒÖÖÆÓ°ÏóÐγɺÍÍ»´¥¹¦Ð§£¬²¢½«Òì³£²¡Àí״̬ѬȾµ½Ïà½üÉñ¾Ôª¡£±ðµÄ£¬»¼Õ߯¤²ãήËõ£¨ÓÈÆä¶îÒ¶ºÍò¨ÉϹµºó²¿ÄÔ¹µÁÑÔö¿í£©£¬ò¨ÖлØÖк£ÂíºÍËó×´»Ø£¬¼°Ð¨Ç°Ò¶ºÍºó¿Û´ø»ØÆ¤ÖʼäÓÐÓÃÅþÁ¬½µµÍ£¬°×ÖÊÍêÕûÐÔÔâµ½ÆÆËð£¬Ò²ÊDZ¬·¢Ó°ÏóÕϰµÄÔµ¹ÊÔÓÉ¡£AβÔÚÄÔ¼¹ÒºÖÐˮƽÔÚÕï¶ÏADÖÐÌØÒìÐÔ90%£¬Ãô¸Ð¶È85%£¬Æäº¬Á¿Ë®Æ½¿ÉÔÚÒ»¶¨Ë®Æ½ÉÏ×÷ΪÇá¶ÈÈÏÖª¹¦Ð§ÕϰϣÍûΪADµÄºã¾Ã¼ì²âÖ¸±ê¡£MRIÓ°Ïñ¿É·¢Ã÷»¼Õߺ£ÂíÌåºÍÄÚÐáÆ¤ÖÊÌå»ýïÔÌ´¦ÓÚADºÍÕý³£ÀÏ»¯Ö®¼ä£¬ÇÒïÔÌËÙÂʸßÓÚÕý³£ÀÏ»¯ÈËȺ£¬º£Âí¡¢ÐÓÈʺˡ¢ò¨Ò¶¡¢¶îÒ¶»ÒÖÊÌå»ýïÔ̺á¹áÓÉMCIÏòADת¹éµÄÕû¸ö²¡³Ì¡£
ÏÖÔÚÒÑÓÐMCIÆÚÏà¹ØÖÎÁÆÒ©Îï»ñÅú¡£2021Äê6ÔÂ7ÈÕ£¬FDAÅú×¼Ê׸ö×èÖ¹°¢¶û´Äº£Ä¬²¡¼²²¡Ï£ÍûÒ©ÎÎÀ²ÄºÍ²³½¡ºÏ×÷¿ª·¢µÄµ¥¿¹Ò©Îïaducanumad¡¿£¬¿ÉÓÐÖúÓÚɨ³ýMCIÆÚ»¼ÕßÄÔÖÐβ-µí·ÛÑùÂѰף»2023Äê1ÔÂLecanemab¡¾ÂØ¿¨Ä¹¡¿ÔÚÃÀ¹ú»ñÅúÓÃÓÚ°¢¶û´Äº£Ä¬²¡£»2024Äê1ÔÂ9ÈÕ£¬ÂØ¿¨Ä¹£¨ÖÐÎÄÉÌÆ·Ãû£ºÔ¸Òâ±££©ÒÑÔÚÖйú»ñÅú£¬ÓÃÓÚÖÎÁÆÓɰ¢¶û´Äº£Ä¬²¡£¨AD£©ÒýÆðµÄÇá¶ÈÈÏÖªÕϰºÍ°¢¶û´Äº£Ä¬²¡Çá¶È³Õ´ô¡£Òò´Ë£¬°¢¶û´Äº£Ä¬²¡µÄÔçɸÔçÕïÏÔµÃÓÈΪÖ÷Òª¡£
Õë¶Ô°¢¶û´Äº£Ä¬²¡½¹µãÉúÎï±ê¼ÇÎïµÄ¼ì²â£¬ÄÔ¼¹ÒººÍÄÔ PET/MRI ³ÉÏñµÈÉúÎï±ê¼ÇÎï¼ì²â½ÏÄÑʵÑé¡£ÄÔ¼¹Òº£¨CSF£©ÉúÎï±ê¼ÇÔÚÎÞÖ¢×´½×¶Î£¬Æäת±äÔçÓÚ PET Ó°Ïñ£¬µ«ÆäÐèÒª×öÓд´µÄÑü×µ´©´Ì£¬×÷Ϊ AD ÔçÆÚɸ²éµÄ¼ì²âÊÖ¶ÎÄÑÒÔ±»»¼Õß½ÓÊÜ¡£ÄÔPET/MRI ³ÉÏñ¿É¼ì²â MCI£¨Çá¶ÈÈÏÖªÕϰ£©¼°ÎÞÖ¢×´ AD£¬µ«ÍíÓÚ CSF ÉúÎï±ê¼ÇÎµ«ÓÉÓÚ¼ÛÇ®ÌÚ¹ó¡¢¼ì²â×°±¸¿É¼°ÐԽϵͣ¬ÇÒ°ÓÚ×¢ÉäÏÔÓ°¼Á¾ßÓнÏÇ¿·ÅÉäÐÔ£¬ÒÀÈ»²»±»»¼Õß½ÓÊÜ¡£ÑªÒº¼ì²â¾ßÓÐÊÕ·Ñ¡¢ÇÖÈëÐÔ¾ùµÍµÄÇ¿ÓÅÊÆ£¬ÊÇ AD ²¡Ö¢ÁÙ´²Õï¶ÏµÄÀíÏ뷶ʽ¡£
2023 Äê 7 ÔÂÓɰ¢¶û´Äº£Ä¬²¡Ð»á£¨AA£©ºÍÃÀ¹ú¹ú¼ÒÀÏÁ仯Ñо¿Ëù£¨NIA£©Ðû²¼ÁËÈ«ÐÂAD¼°ÆäËû³Õ´ôµÄÔ¤·À¼°ÕïÁÆÖ¸ÄÏ¡¶NIA-AA Revised Clinical Guidelines for Alzheimer’s¡·£»ÐÞ¶©²Ý°¸ÖÐÊ×´ÎÒýÈëÁËѪҺÉúÎï±ê¼ÇÎÃ÷ȷѪҺÀàÐÍΪѪ½¬¡£Ö¸µ¼Î¯Ô±»áµÄ³ÉÔ±½¨Ò飬»ùÓÚѪҺµÄÉúÎï±ê¼ÇÎï¼ì²â½«Äܹ»Ìṩ»¼Õ߸üÔçµÄ׼ȷÕï¶Ï£¬²¢ÓÐÖúÓÚÈ·¶¨Ïà¹ØµÄÑо¿ÊÔÑéºÍ»ñµÃ¾Åú×¼µÄÉúÎï±ê¼ÇÎï°ÐÏòÖÎÁÆÒªÁì¡£
±í3£º°¢¶û´Äº£Ä¬²¡ÉúÎï±ê¼ÇÎïÁÙ´²¼ÛÖµ[2]
9888À˹ά¼Ó˹°¬ÆÕÄܹ»Ìṩ°¢¶û´Äº£Ä¬²¡ÈýÏîºÍÁùÏîѪҺ±ê¼ÇÎï¼ì²â£¬¿ÉÓÃÓÚ¸¨Öú°¢¶û´Äº£Ä¬²¡µÄÔçÆÚÕï¶Ï£¬¼à²â°¢¶û´Äº£Ä¬²¡¼²²¡µÄÏ£ÍûÇéÐΡ£
²Î¿¼ÎÄÏ×
[1] 2018Öйú³Õ´ôÓëÈÏÖªÕϰÕïÖÎÖ¸ÄÏ(Ò»):³Õ´ô¼°Æä·ÖÀàÕï¶Ï±ê×¼[J]. ÖлªÒ½Ñ§ÔÓÖ¾, 2018, 98(13): 965-970.
[2] NIA-AA Revised Clinical Guidelines for Alzheimer’s. AAIC